NEW

Health Care Leaders Form Trustworthy & Responsible AI Network (TRAIN)

Monday, at the HIMSS 2024 Global Health Conference, a new consortium of healthcare leaders announced the creation of the Trustworthy & Responsible AI Network (TRAIN), which aims to operationalize responsible AI principles to improve the quality, safety and...

EPA Rule to Slash EtO Emissions, Reduce Cancer Risk

The U.S. Environmental Protection Agency has announced a rule that will reduce lifetime cancer risks for people living near commercial sterilization facilities across the country. The final amendments to the air toxics standards for ethylene oxide commercial...

AI Revolutionizes General Surgery, says GlobalData

Artificial intelligence (AI) integration in general surgery has surged, promising revolutionary advancements in precision and patient outcomes. AI tools have transformed preoperative planning, intraoperative assistance, and postoperative care, enhancing diagnostic...

Study Shows Potential for Using AI Tools to Detect Healthcare-Associated Infections

A new proof-of-concept study published today in the American Journal of Infection Control (AJIC) reports that artificial intelligence (AI) technologies can accurately identify cases of healthcare-associated infections (HAI) even in complex clinical scenarios. The...

Tru-D SmartUVC to Exhibit at AORN Expo

A leader in the UV disinfection industry, Tru-D SmartUVC will exhibit its patented “smart” technology at the Association for Perioperative Registered Nurses’ (AORN) Surgical Conference and Expo 2016 in Boston, Massachusetts April 2-4, 2017 at booth #1748. In addition to exhibiting and attending the AORN Surgical Conference, Tru-D has proudly joined the 2500 Club as a sponsor of the AORN Foundation. The industry standard in advocating for excellence in perioperative practice and health care, AORN provides perioperative nurses with education and resources for safe clinical practice and professional development.

“Hospital-acquired infections including surgical-site infections continue to be top-of-mind for patient safety and care in health care facilities,” said Chuck Dunn, president and CEO of Tru-D SmartUVC. “Tru-D has been validated to reduce the risk of infection by the only randomized clinical trial on UV disinfection, and we are excited to share the study’s results and our technology with attendees of AORN.”

The recently-published Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study which was funded by the Centers for Disease Control and Prevention Epicenter Program and conducted across the Duke Infection Control Outreach Network showed that Tru-D is able to reduce the risk of infection of C. diff, MRSA, VRE and Acinetobacter among patients admitted to the same room by a cumulative 30 percent. Conducted throughout nine hospitals for a total of 600,000 room stays and more than 22,000 Tru-D cycles completed, the BETR-D randomized clinical trial is the most comprehensive study on UV disinfection to date.

“Tru-D is the only ‘smart’ UV disinfection robot with patented Sensor360 technology that can guarantee a baseline of disinfection and thorough operating room disinfection with every cycle,” said Dunn. “Tru-D’s basis of scientific evidence and widespread adoption throughout prestigious hospital systems continues to drive market acceptance of UV disinfection technology.”

Tru-D is deployed in hospital and operating rooms after an environmental services member cleans the area with traditional cleaning methods. Using chemical-free UVC energy, Tru-D operates from a single position and administers a single cycle of UV light, easily integrating into a hospital’s existing workflow with minimal labor impact. Through the use of its patented Sensor360 technology, Tru-D analyzes the space including size, shape and contents, to deliver a precise, lethal dose of UV light, achieving significant pathogen reduction in the room. While the cycle is being performed, operators are free to tend to other tasks and are alerted via audio and/or text message when disinfection is complete.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X